Key Takeaways
- • Bessemer Venture Partners X L.P. sold 725,000 shares of Hinge Health (HNGE) Class A Common Stock on November 18, 2025, generating $29.04 million in proceeds at $40.05 per share.
- • The transaction represents a partial exit by a significant early-stage investor, with Bessemer retaining 7.49 million shares valued at approximately $322 million as of November 18, 2025, maintaining a roughly 10% ownership stake in the NYSE-listed healthcare technology company.
- • The sale reflects post-IPO liquidity events for venture capital investors in Hinge Health, which completed its initial public offering on May 22, 2025, and now trades under ticker HNGE.
- • Bessemer Venture Partners' continued material stake signals ongoing confidence in the company despite the secondary share disposition, as the fund maintains substantial exposure to the digital musculoskeletal health platform.
Summary
Bessemer Venture Partners X L.P., a major venture capital investor in digital health, executed a secondary offering of Hinge Health shares on November 18, 2025, selling 725,000 shares of Class A Common Stock at $40.05 per share for aggregate proceeds of $29,036,249. The transaction was reported as an insider filing under securities regulations and represents a partial liquidity event for the early-stage investor following Hinge Health's May 2025 NYSE debut under ticker HNGE.
As of the transaction date, Bessemer Venture Partners X L.P. retained 7,492,414 shares of Hinge Health, valued at approximately $322 million based on the transaction price. This remaining position represents roughly a 10% ownership stake in the company, indicating that the fund's sale constituted a modest reduction of its total holdings rather than a complete exit. The continued material ownership stake suggests the venture capital firm maintains confidence in Hinge Health's long-term value proposition despite the partial position reduction.
The sale underscores typical post-IPO capital allocation dynamics, where early-stage venture investors begin executing partial liquidity strategies following the transition from private to public markets. Hinge Health has attracted substantial institutional capital, having raised $854 million in total funding from prominent investors including Tiger Global Management, Coatue, and Insight Partners prior to its public market entry. The company operates a digital musculoskeletal health platform and has positioned itself as a participant in the broader Health Tech 2.0 investment thesis outlined by Bessemer Venture Partners in its state-of-the-art healthcare innovation analysis.
As of the transaction date, Bessemer Venture Partners X L.P. retained 7,492,414 shares of Hinge Health, valued at approximately $322 million based on the transaction price. This remaining position represents roughly a 10% ownership stake in the company, indicating that the fund's sale constituted a modest reduction of its total holdings rather than a complete exit. The continued material ownership stake suggests the venture capital firm maintains confidence in Hinge Health's long-term value proposition despite the partial position reduction.
The sale underscores typical post-IPO capital allocation dynamics, where early-stage venture investors begin executing partial liquidity strategies following the transition from private to public markets. Hinge Health has attracted substantial institutional capital, having raised $854 million in total funding from prominent investors including Tiger Global Management, Coatue, and Insight Partners prior to its public market entry. The company operates a digital musculoskeletal health platform and has positioned itself as a participant in the broader Health Tech 2.0 investment thesis outlined by Bessemer Venture Partners in its state-of-the-art healthcare innovation analysis.
Go deeper than the headline
Research every firm in this story, track the ones that matter and get the daily briefing — free for 7 days.